NHF in Acute Hypercapnic Acute Exacerbation of COPD

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03523481

Enrollment

Registered

2018-05-14

Start date

2018-05-15

Completion date

2018-05-30

Last updated

2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety of NHF in Acute Hypercapnic AECOPD

Brief summary

Patients with AECOPD and NIV failure and in absence will be treated with NHF device. Inclusion criteria are pH \< 7,38 and pCO2 \> 45 mm Hg. Patients were treated if pH \>7,38 or refusal of therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* pH \< 7,38 * hypercapnic AECOPD

Exclusion criteria

* Need of intubation

Design outcomes

Primary

Measure	Time frame	Description
pH	up to 24 hours	Increase in pH

Secondary

Measure	Time frame	Description
pCO2	up to 24 hours	Decrease in pCO2

Countries

Germany

Outcome results